Source:http://linkedlifedata.com/resource/pubmed/id/11001075
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2000-10-12
|
pubmed:abstractText |
The cytokines that contribute to airway inflammation, including interleukin-1beta (IL-1beta) and tumour necrosis factor alpha (TNFalpha), might have key roles in the development of chronic obstructive pulmonary disease (COPD). Interleukin-1 receptor antagonist (IL-1RN), the physiological antagonist of IL-1beta, is also known to play a crucial role in several chronic inflammatory diseases. In this study, we investigated the association of the polymorphisms of IL-1beta, IL-1RN and TNFalpha with susceptibility to COPD. To elucidate the genotype of the IL-1beta polymorphisms at position -511 base and at the amino acid residue 105, the IL-1RN polymorphism in intron 2, and TNFalpha polymorphism at position -308, polymerase chain reaction (PCR) and restriction enzyme fragment length polymorphism (RFLP) were performed on blood samples from both patients with COPD (n = 53) and control subjects (n = 65). There were no differences on the allele and genotype frequency of IL-1beta, IL-1RN, and TNFalpha between the two groups. We could not find a significant link between the polymorphism of TNFalpha, which was previously reported to be associated with chronic bronchitis, and COPD. Furthermore, no association between genetic polymorphisms of IL-1beta and IL-1RN and individual susceptibility to COPD was found.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0954-6111
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
847-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11001075-Aged,
pubmed-meshheading:11001075-Alleles,
pubmed-meshheading:11001075-Case-Control Studies,
pubmed-meshheading:11001075-Genetic Predisposition to Disease,
pubmed-meshheading:11001075-Genotype,
pubmed-meshheading:11001075-Humans,
pubmed-meshheading:11001075-Interleukin-1,
pubmed-meshheading:11001075-Lung Diseases, Obstructive,
pubmed-meshheading:11001075-Male,
pubmed-meshheading:11001075-Middle Aged,
pubmed-meshheading:11001075-Polymerase Chain Reaction,
pubmed-meshheading:11001075-Polymorphism, Genetic,
pubmed-meshheading:11001075-Receptors, Interleukin-1,
pubmed-meshheading:11001075-Risk Factors,
pubmed-meshheading:11001075-Smoking,
pubmed-meshheading:11001075-Tumor Necrosis Factor-alpha
|
pubmed:year |
2000
|
pubmed:articleTitle |
Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD.
|
pubmed:affiliation |
Department of Geriatric Medicine, University of Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|